Form 4: Travere Therapeutics Executive Sandra Calvin Reports Stock Option Exercise and Sale
SEC Form 4
Sandra Calvin, SVP and Chief Accounting Officer of Travere Therapeutics, exercised stock options and sold shares on February 11, 2025, according to a recent SEC Form 4 filing.
Summary
- On February 11, 2025, Sandra Calvin, the SVP and Chief Accounting Officer of Travere Therapeutics, exercised stock options to acquire a total of 45,000 shares of common stock at prices ranging from $15.46 to $17.96.
- On the same day, Calvin sold 54,244 shares of common stock at a price of $25 per share.
- These transactions were executed under a pre-arranged 10b5-1 trading plan adopted on September 9, 2024.
- Following these transactions, Calvin directly owns 54,410 shares of Travere Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive, with neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and provides insight into the actions of company executives, which can be of interest to investors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| September 9, 2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| February 11, 2025 | Date of stock option exercise and sale of shares. |
| May 19, 2026 | Expiration date of one of the stock option grants. |
| May 17, 2027 | Expiration date of one of the stock option grants. |
| May 9, 2029 | Expiration date of one of the stock option grants. |
| January 31, 2030 | Expiration date of one of the stock option grants. |
Keywords
Form 4, Travere Therapeutics, TVTX, Insider Trading, Stock Options, Sandra Calvin, SEC Filing, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.